Testosterone Lawsuit News: New Study Finds Low Testosterone Therapy May Negatively Affect the Brain in Certain Men, Bernstein Liebhard LLP Reports

• 

A number of testosterone treatment lawsuits have been filed in courts around the country on behalf of men who allegedly experienced serious heart events due to AndroGel and Testim.

New York, New York (PRWEB) April 10, 2014

As testosterone lawsuits (http://www.testosteronelawsuitcenter.com/)
filed on behalf of men who were allegedly injured by AndroGel, Testim and other low testosterone therapies continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a new study has found that the use of these drugs in certain men may have negative consequences for the brain. The study, which was published this month in the Journal of Alzheimer’s Disease, found that low testosterone therapy appears to damage brain cells in Caucasian men with elevated levels of oxidative stress, which may raise their risk of dementia. *

The negative impacts were not seen among men of other races who were included in the study. In a press release detailing their findings, its authors recommended that Caucasian men undergo testing for oxidative stress before beginning low testosterone therapy. **

“A number of testosterone treatment lawsuits have been filed in courts around the country on behalf of men who allegedly experienced serious heart events due to AndroGel and Testim. This study just serves to remind that this class of medications may be associated with some significant risks,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal reviews to anyone who allegedly suffered serious cardiovascular problems due to the use of prescription testosterone therapies.
Testosterone Treatment Lawsuits

Low testosterone therapies, such as AndroGel and Testim, are approved to treat hypogonadism (low testosterone) in men who suffer from the condition due to an underlying medical disorder or injury. In January, the U.S. Food & Drug Administration (FDA) announced it was reviewing possible heart risks associated with prescription testosterone treatments, after two studies indicated the drugs might result in an increased risk of heart attacks, strokes and sudden cardiac death in older men or those with pre-existing heart disease.

Since then, court documents indicate that more than 30 AndroGel lawsuits have been filed in federal courts around the U.S. on behalf of men who allegedly suffered heart attacks, strokes, heart failure, and dangerous blood clots due to their use of the medication. On March 28th, plaintiffs in these lawsuits asked the U.S. Judicial Panel on Multidistrict Litigation to transfer all of these cases to the U.S. District Court, Northern District of Illinois for coordinated pretrial proceedings. Among other things, their brief noted that the majority of AndroGel lawsuits filed thus far were pending in the Northern District of Illinois, and they asserted that many additional filings are likely. (In Re: AndroGel Product Liability Litigation, No. 36, JPML)

In addition to AndroGel, court filings show that a number of testosterone lawsuits have been filed against the manufacturer of Testim. These include two claims that were filed last month in the U.S. District Court, Eastern District of Pennsylvania. (Case Nos. 140301684 and 140302537). Those cases followed the filing of a Testim lawsuit in February in the U.S. District Court, Northern District of California in February. (Case No. No. 14-278)

Men who suffered life-threatening cardiovascular events allegedly due to AndroGel, Testim, or other low testosterone therapies may be entitled to compensation for their injury-related damages. To learn more about the litigation involving prescription testosterone medications, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*iospress.metapress.com/content/t1717503235m8667/?p=6faa1459b80b468b8228116bca499efb&pi=1 Journal of Alzheimer’s Disease, April 2014
**hsc.unt.edu/news/newsrelease.cfm?ID=1393#.U0avd1fIn3U, UNT Health Science Center, April 2, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

PDF Print